PEPTIDOTS-IL2 (CARLINA Technologies)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePEPTIDOTS-IL2 (CARLINA Technologies)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsKidney NeoplasmsSkin Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCARLINA Technologies SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCARLINA Technologies SAS
Active IndicationsN/A
Inactive IndicationsKidney NeoplasmsSkin Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A